Agf Investments Inc. Charles River Laboratories International, Inc. Transaction History

Agf Investments Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$255.51 - $362.11 $6,898 - $9,776	-27 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$372.64 - $458.3 $1,490 - $1,833	-4 Reduced 12.9%	27 $11,000
Q2 2021 Aug 10, 2021	SELL	$294.17 - $371.65 $3,235 - $4,088	-11 Reduced 26.19%	31 $11,000
Q1 2021 May 14, 2021	BUY	$249.67 - $299.48 $10,486 - $12,578	42 New	42 $12,000
Q2 2020 Aug 11, 2020	SELL	$118.84 - $189.72 $1,069 - $1,707	-9 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$98.9 - $178.34 $890 - $1,605	9 New	9 $1,000

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Agf Investments Inc., based on Form 13F filings with the SEC.

Stay updated on Agf Investments Inc. with notifications on news.